Thomas Martin, MD, obtained his undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine in 1989. After completing his internal medicine residency program at Harbor-UCLA Medical Center in 1992, he obtained his fellowship in hematological oncology at UCSF in 1996. Dr Martin was an Assistant Professor of Medicine in MD Anderson Cancer 2 years before returning to UCSF as a Hematologist-Oncologist.
Dr Martin is currently a Clinical Research Director of Hematologic Malignancies UCSF Helen Diller Family Comprehensive Cancer Center.
Speaking on treatments for myeloma and leukemia
Dr Martin’s research focuses on the development of treatments for myeloma and leukemia, including bone marrow transplants. His most recent work involves the use of CAR T-cell therapy targeting B-cell maturation antigen (BCMA) in patients with refractory multiple myeloma.